SECTM1 and central nervous system cancer: 1p/19q chromosome co-deletion has been considered as a diagnostic and prognostic marker for oligodendroglioma since 199831, and the high expression of SECTM1 in 1p/19q non-codel indicates that SECTM1 expression is significantly correlated with the survival and prognosis of glioma patients.